First Imported Case of SARS-CoV-2 Omicron Subvariant BA.5 - Shanghai Municipality, China, May 13, 2022

Hui Jiang; Changcheng Wu; Wenbo Xu; Hongyou Chen; Fanghao Fang; Min Chen; Chaonan Wang; Lingyue Yuan; Huanyu Wu; Zheng Teng; Jinyuan Guo; Yaxu Zheng; Xihong Lyu; Xuefei Qiao; Guizhen Wu; Wenjie Tan; Xi Zhang

doi:10.46234/ccdcw2022.104

First Imported Case of SARS-CoV-2 Omicron Subvariant BA.5 - Shanghai Municipality, China, May 13, 2022

China CDC Wkly. 2022 Jul 29;4(30):665-666. doi: 10.46234/ccdcw2022.104.

Authors

Hui Jiang¹, Changcheng Wu², Wenbo Xu², Hongyou Chen¹, Fanghao Fang¹, Min Chen¹, Chaonan Wang¹, Lingyue Yuan¹, Huanyu Wu¹, Zheng Teng¹, Jinyuan Guo², Yaxu Zheng¹, Xihong Lyu³, Xuefei Qiao³, Guizhen Wu², Wenjie Tan², Xi Zhang¹

Affiliations

¹ Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
² National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.
³ Songjiang District Center for Disease Control and Prevention, Shanghai, China.

No abstract available

Keywords: COVID-19; Omicrons Subvariant; SARS-CoV-2; variant of concern.

Grants and funding

Supported by the National Key Research and Development Program of China (2021YFC0863300) and Three-Year Initiative Plan for Strengthening Public Health System Construction in Shanghai (GWV-2)